⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503376 | 1.00 | — | — | |
| SCHEMBL503383 | 1.00 | — | — | |
| SCHEMBL500669 | 0.98 | GGT1 (0.42) | — | |
| Water SCHEMBL27459592 | 0.98 | GGT1 (0.42) | — | |
| Hydrochloric Acid SCHEMBL74583 | 0.98 | GGT1 (0.42) | — | |
| Water SCHEMBL7508586 | 0.98 | GGT1 (0.42) | — | |
| Water SCHEMBL18669981 | 0.88 | TSHR (0.39) | — | |
| SCHEMBL5488304 | 0.79 | HTT (0.33) | — | |
| Bicarbonate SCHEMBL8039493 | 0.78 | HTT (0.38) | — | |
| SCHEMBL2481158 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016943-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2024-01-18 | — | — | US | claimed |
| EP-4251642-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | The University of Chicago (US) | 2023-10-04 | — | — | EP | claimed |
| WO-2022115595-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2022-06-02 | — | — | WO | claimed |
| EP-3698810-A1 | STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE | Dana Farber Cancer Institute, Inc. (US) | 2020-08-26 | — | — | EP | claimed |
| EP-3698811-A1 | STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE | Dana Farber Cancer Institute, Inc. (US) | 2020-08-26 | — | — | EP | claimed |
| WO-2018112226-A1 | SHARPIN-BASED POLYPEPTIDES AND THEIR USES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-06-21 | — | — | WO | claimed |
| EP-0833626-B1 | MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS | H GEN B V (NL) | 2003-03-05 | — | — | EP | claimed |
| CN-120202211-A | Cyclic compounds having selective KRAS inhibition over HRAS and NRAS | 中外制药株式会社 | 2025-06-24 | — | — | CN | disclosed |
| CN-119866342-A | Cyclic peptides for capturing interleukin-1 beta | 默沙东有限责任公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119731195-A | Cyclic compounds having selective inhibition of KRAS over HRAS and NRAS | 中外制药株式会社 | 2025-03-28 | — | — | CN | disclosed |
| EP-4504732-A2 | NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF | University of Connecticut (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-118879592-A | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-11-01 | — | — | CN | disclosed |
| EP-4399220-A1 | ANTIVIRAL STRUCTURALLY-STAPLED SARS-COV-2 PEPTIDE- CHOLESTEROL CONJUGATES AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| US-6780573-B1 | ADEQUATE DIFFUSION RESISTANCE WITHOUT BALLAST; MINIMIZED SPEED LOSS; GREATER INTERIMAGE; EFFICIENT REMOVAL | EASTMAN KODAK COMPANY | 2004-08-24 | — | — | US | disclosed |
| US-20030167129-A1 | Binding compounds and methods for identifying binding compounds | IWA, LLC | 2003-09-04 | — | — | US | disclosed |
| EP-0833626-B1 | MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS | H GEN B V (NL) | 2003-03-05 | — | — | EP | disclosed |
| US-20030018438-A1 | Binding compounds and methods for identifying binding compounds | IWA, LLC | 2003-01-23 | — | — | US | disclosed |
| WO-2002057313-A2 | RECEPTOR-BINDING COMPOUNDS AND METHODS FOR IDENTIFYING THEM | CONSENSUS PHARMACEUTICALS, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| US-5268476-A | Substituted 10bH-oxazolo[3,2-c] [1,3] benzoxazine-2(3H), 5-diones | ABBOTT LABORATORIES (US) | 1993-12-07 | — | — | US | disclosed |
| US-5153358-A | Process for the preparation of alpha-alkylated alpha-amino acids and alpha-halogenated alpha-amino acids | ABBOTT LABORATORIES (US) | 1992-10-06 | — | — | US | disclosed |